290 related articles for article (PubMed ID: 11914273)
1. A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling.
Shvarts A; Brummelkamp TR; Scheeren F; Koh E; Daley GQ; Spits H; Bernards R
Genes Dev; 2002 Mar; 16(6):681-6. PubMed ID: 11914273
[TBL] [Abstract][Full Text] [Related]
2. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence.
Peeper DS; Shvarts A; Brummelkamp T; Douma S; Koh EY; Daley GQ; Bernards R
Nat Cell Biol; 2002 Feb; 4(2):148-53. PubMed ID: 11812999
[TBL] [Abstract][Full Text] [Related]
3. Functional identification of LRF as an oncogene that bypasses RASV12-induced senescence via upregulation of CYCLIN E.
Vredeveld LC; Rowland BD; Douma S; Bernards R; Peeper DS
Carcinogenesis; 2010 Feb; 31(2):201-7. PubMed ID: 19942610
[TBL] [Abstract][Full Text] [Related]
4. The ARF tumor suppressor inhibits BCL6-mediated transcriptional repression.
Suzuki H; Kurita M; Mizumoto K; Moriyama M; Aiso S; Nishimoto I; Matsuoka M
Biochem Biophys Res Commun; 2005 Jan; 326(1):242-8. PubMed ID: 15567177
[TBL] [Abstract][Full Text] [Related]
5. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras.
Pantoja C; Serrano M
Oncogene; 1999 Sep; 18(35):4974-82. PubMed ID: 10490832
[TBL] [Abstract][Full Text] [Related]
6. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
7. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
[TBL] [Abstract][Full Text] [Related]
8. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
Phan RT; Dalla-Favera R
Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
[TBL] [Abstract][Full Text] [Related]
9. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
Palmero I; Murga M; Zubiaga A; Serrano M
Oncogene; 2002 May; 21(19):2939-47. PubMed ID: 12082524
[TBL] [Abstract][Full Text] [Related]
10. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells.
Phan RT; Saito M; Basso K; Niu H; Dalla-Favera R
Nat Immunol; 2005 Oct; 6(10):1054-60. PubMed ID: 16142238
[TBL] [Abstract][Full Text] [Related]
11. Ectopic expression of cyclin D1 impairs the proliferation and enhances the apoptosis of a murine lymphoid cell line.
Duquesne F; Florent M; Roué G; Troussard X; Sola B
Cell Death Differ; 2001 Jan; 8(1):51-62. PubMed ID: 11313703
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock.
Munro J; Barr NI; Ireland H; Morrison V; Parkinson EK
Exp Cell Res; 2004 May; 295(2):525-38. PubMed ID: 15093749
[TBL] [Abstract][Full Text] [Related]
13. Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation.
Deneen B; Denny CT
Oncogene; 2001 Oct; 20(46):6731-41. PubMed ID: 11709708
[TBL] [Abstract][Full Text] [Related]
14. Escape from premature senescence is not sufficient for oncogenic transformation by Ras.
Peeper DS; Dannenberg JH; Douma S; te Riele H; Bernards R
Nat Cell Biol; 2001 Feb; 3(2):198-203. PubMed ID: 11175753
[TBL] [Abstract][Full Text] [Related]
15. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
16. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
Santoni-Rugiu E; Duro D; Farkas T; Mathiasen IS; Jäättelä M; Bartek J; Lukas J
Oncogene; 2002 Sep; 21(42):6498-509. PubMed ID: 12226753
[TBL] [Abstract][Full Text] [Related]
17. p53-Dependent and -independent functions of the Arf tumor suppressor.
Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
[TBL] [Abstract][Full Text] [Related]
18. TSG101 expression in gynecological tumors: relationship to cyclin D1, cyclin E, p53 and p16 proteins.
Bennett NA; Pattillo RA; Lin RS; Hsieh CY; Murphy T; Lyn D
Cell Mol Biol (Noisy-le-grand); 2001 Nov; 47(7):1187-93. PubMed ID: 11838966
[TBL] [Abstract][Full Text] [Related]
19. Cellular senescence induced by p53-ras cooperation is independent of p21waf1 in murine embryo fibroblasts.
Castro ME; del Valle Guijarro M; Moneo V; Carnero A
J Cell Biochem; 2004 Jun; 92(3):514-24. PubMed ID: 15156563
[TBL] [Abstract][Full Text] [Related]
20. A large-scale RNAi screen in human cells identifies new components of the p53 pathway.
Berns K; Hijmans EM; Mullenders J; Brummelkamp TR; Velds A; Heimerikx M; Kerkhoven RM; Madiredjo M; Nijkamp W; Weigelt B; Agami R; Ge W; Cavet G; Linsley PS; Beijersbergen RL; Bernards R
Nature; 2004 Mar; 428(6981):431-7. PubMed ID: 15042092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]